Case report describes copper deficiency myelopathy in a patient following tirzepatide therapy, highlighting nutritional risks.
To describe a case of copper deficiency myelopathy presenting as progressive spastic quadriparesis and malnutrition following substantial weight loss associated with tirzepatide (Mounjaro) use.
No takes yet. Share an insight, caveat, or question.
Willis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: